Recherche Fr menu ClientConnect
5 premiers résultats de la recherche Voir tous les résultats Recherche avancée
Recherches les plus fréquentes
Pages les plus visitées
    Référence: 20200395
    Date de publication: 25 mai 2020

    Promoteur – Intermédiaire Financier




    The project consists in programme loan to support public sector counterparties in containing the COVID-19 pandemic with health emergency response and pandemic preparedness interventions for Eastern, Central Asia and Southern neighbouring countries.


    Objectives of the EIB financing are twofold: 1) The main scope of the operation is addressing the medical emergency response, for which the EIB is ensuring a fast financial support that will: a) enable the promoters to deploy the healthcare infrastructure, equipment and materials required to fight the COVID-19 expansion, increase intensive care unit capacity for patients with respiratory diseases (respiration equipment etc.), lab capacities for testing, IT and other equipment and software for logistics, stockpiling, transport, surveillance, etc,; b) enable the the civil protection sector, for example, to increase capacity for healthcare beyond the normal system, including equipment and infrastructure, hygiene and disinfection measures, examinations, screening, quarantines and other official measures ordered to prevent the spread of infectious diseases. 2) The other objective is to address the pandemic medium term response. Given the general underinvestment of the healthcare system across the Eastern, Central Asia and Southern neighbouring countries region, the programme loan could also be used to finance investments to reinforce the healthcare systems of the target countries to better respond to future pandemic threats.


    this operations falls under the ELM 2014-2020 and if needed subsequent EC guarantees


    • Santé - Santé humaine et action sociale

    Garantie au titre du MPE

    This operation is covered by the ELM Guarantee.

    Montant BEI envisagé (montant approximatif)

    EUR 670 million

    Coût total (montant approximatif)

    EUR 750 million

    Aspects environnementaux

    The project, even if located in the EU, would not be covered by Annex II of the Environmental Impact Assessment (EIA) Directive 2014/52/EU, amending Directive 2011/92/EU, in relation to urban development. The implementation of the projects has to comply with the EIB's Environmental and Social principles and standards.

    Passation des marchés

    Any procurement procedures has to comply with the EIB's Guide to Procurement and the relevant applicable EU public procurement rules (for potential candidate countries).


    Approuvé - 11/06/2020

    Clause de non-responsabilité

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Mots-clés correspondants

    Biélorussie Égypte Jordanie Rep. De Moldova Maroc Tunisie Ouzbekistan Santé